4//SEC Filing
Paulson Richard A. 4
Accession 0000950170-24-122274
CIK 0001503802other
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 4:06 PM ET
Size
5.3 KB
Accession
0000950170-24-122274
Insider Transaction Report
Form 4
Paulson Richard A.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-11-05$0.91/sh−3,675$3,346→ 1,131,932 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.
- [F2]Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $0.9101 to $0.9350, inclusive. The reporting person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001804460
Filing Metadata
- Form type
- 4
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 6, 4:06 PM ET
- Size
- 5.3 KB